Comparative Cardiovascular Outcomes of SGLT2 Inhibitors in Type 2 Diabetes Mellitus: A Network Meta-Analysis of Randomized Controlled Trials. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.